dc.creator | Kourkouni E., Mitsogiannis G., Simopoulou T., Liaskos C., Katsiari C.G., Daniil Z., Gourgoulianis K., Bogdanos D.P., Sakkas L.I. | en |
dc.date.accessioned | 2023-01-31T08:45:36Z | |
dc.date.available | 2023-01-31T08:45:36Z | |
dc.date.issued | 2019 | |
dc.identifier | 10.31138/mjr.30.3.186 | |
dc.identifier.issn | 24593516 | |
dc.identifier.uri | http://hdl.handle.net/11615/75328 | |
dc.description.abstract | Anti-synthetase syndrome is an autoimmune disorder characterized by the presence of autoantibodies against aminoacyl transfer RNA (tRNA) synthetases, and myositis, interstitial lung disease (ILD), arthritis, fever and Raynaud's phenomenon (RP). We present a 54-year-old woman, who complained of fatigue, low-grade fever, myalgias, arthralgias, RP and dyspnoea on exertion. Chest CT scan revealed features of interstitial lung disease. Due to rapid deterioration of her lung function, she required oxygen support. The patient did not respond to empiric treatment with antibiotics. Autoantibody testing was remarkable for ANA positivity (1/160) and high-titre anti-Jo1 positivity. A diagnosis of anti-synthetase syndrome was made and the patient was placed on high-dose corticosteroids and rituximab with significant improvement. At 1-year follow up, she remains in good condition, without the need for oxygen supplementation. © Kourkouni E, Mitsogiannis G, Simopoulou T, Liaskos C, Katsiari CG, Daniil Z, Gourgoulianis K, Bogdanos DP, Sakkas LI. | en |
dc.language.iso | en | en |
dc.source | Mediterranean Journal of Rheumatology | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85114279136&doi=10.31138%2fmjr.30.3.186&partnerID=40&md5=762c094f036a5ec585a2c5676dd73d8e | |
dc.subject | antibody | en |
dc.subject | antinuclear antibody | en |
dc.subject | bronchodilating agent | en |
dc.subject | C reactive protein | en |
dc.subject | clarithromycin | en |
dc.subject | cotrimoxazole | en |
dc.subject | creatine kinase | en |
dc.subject | Jo 1 antibody | en |
dc.subject | methylprednisolone | en |
dc.subject | moxifloxacin | en |
dc.subject | oseltamivir | en |
dc.subject | oxygen | en |
dc.subject | piperacillin plus tazobactam | en |
dc.subject | prednisolone | en |
dc.subject | rituximab | en |
dc.subject | Ro52 antibody | en |
dc.subject | unclassified drug | en |
dc.subject | adult | en |
dc.subject | allergic pneumonitis | en |
dc.subject | antisynthetase syndrome | en |
dc.subject | arterial oxygen saturation | en |
dc.subject | arthralgia | en |
dc.subject | arthritis | en |
dc.subject | Article | en |
dc.subject | autoimmune disease | en |
dc.subject | bronchiectasis | en |
dc.subject | case report | en |
dc.subject | Caucasian | en |
dc.subject | clinical article | en |
dc.subject | computer assisted tomography | en |
dc.subject | differential diagnosis | en |
dc.subject | drug dose reduction | en |
dc.subject | drug megadose | en |
dc.subject | dyspnea | en |
dc.subject | fatigue | en |
dc.subject | female | en |
dc.subject | fever | en |
dc.subject | follow up | en |
dc.subject | forced expiratory volume | en |
dc.subject | forced vital capacity | en |
dc.subject | human | en |
dc.subject | hypoxia | en |
dc.subject | interstitial lung disease | en |
dc.subject | laboratory test | en |
dc.subject | lung disease | en |
dc.subject | lung function test | en |
dc.subject | lung infiltrate | en |
dc.subject | medical history | en |
dc.subject | middle aged | en |
dc.subject | myalgia | en |
dc.subject | myositis | en |
dc.subject | oxygen therapy | en |
dc.subject | prescription | en |
dc.subject | Raynaud phenomenon | en |
dc.subject | respiratory tract infection | en |
dc.subject | rheumatic disease | en |
dc.subject | rheumatoid arthritis | en |
dc.subject | sarcoidosis | en |
dc.subject | Sjoegren syndrome | en |
dc.subject | systemic lupus erythematosus | en |
dc.subject | systemic sclerosis | en |
dc.subject | tachypnea | en |
dc.subject | thorax radiography | en |
dc.subject | vasculitis | en |
dc.subject | Greek Rheumatology Society and Professional Association of Rheumatologists | en |
dc.title | Interstitial lung disease in anti-synthetase syndrome | en |
dc.type | journalArticle | en |